Title: Pharmacological and clinical studies of rotigotine transdermal patch
Abstract: Rotigotine transdermal patch is approved by the US FDA for the treatment of early Parkinson's disease.It is the first available transdermal patch for this disease.It can delivery drug through the skin to maintain 24-h plasma levels stably and stimulate dopamine receptor continuously.This paper reviewed the mechanism,pharmacokinetics,pharmacodynamics,clinical studies,drug interactions and adverse reactions of rotigotine transdermal patch.
Publication Year: 2008
Publication Date: 2008-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot